Brody's human pharmacology : (Record no. 17287)

000 -LEADER
fixed length control field 07704cam a2200661Ii 4500
001 - CONTROL NUMBER
control field on1046991162
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20200515210628.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 180802t20192019paua ob 000 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency MMU
Language of cataloging eng
Description conventions rda
Transcribing agency
Modifying agency
--
--
--
--
--
--
--
--
--
--
--
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780323596626
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0323596622
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780323596640
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0323596649
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780323476522
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 032347652X
Qualifying information (electronic bk.)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1046991162
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM300
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 4
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.5/8
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Brody's human pharmacology :
Remainder of title mechanism-based therapeutics /
Statement of responsibility, etc. [edited by] Lynn Wecker ; with David A. Taylor, Robert James Theobald, Jr.
246 3# - VARYING FORM OF TITLE
Title proper/short title Human pharmacology
246 3# - VARYING FORM OF TITLE
Title proper/short title Brody's human pharmacology :
Remainder of title molecular to clinical
250 ## - EDITION STATEMENT
Edition statement Sixth edition.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Philadelphia, PA :
Name of producer, publisher, distributor, manufacturer Elsevier, Inc.,
Date of production, publication, distribution, manufacture, or copyright notice [2019]
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice �2019
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xiv, 728 pages) :
Other physical details color illustrations
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Section 1: Mechanisms of drug action and therapeutic principles. -- Introduction, terminology -- Pharmacodynamics: drug targets (receptors, enzymes, DNA, etc) -- Pharmacokinetics -- Pharmacogenomics -- Drug discovery, development, and regulation -- Section 2: Chemical mediators and drugs affecting autonomic and neuromuscular synapses. -- Introduction to the peripheral nervous systems and drugs for peripheral disorders -- Cholinergic drugs -- Muscarinic agonists and their clinical uses -- Muscarinic antagonists and their clinical uses -- Nicotinic agonists and their clinical uses -- Nicotinic antagonists and neuromuscular blocking drugs -- Adrenergic drugs -- Adrenergic agonists and their clinical uses -- Adrenergic antagonists and their clinical uses -- Section 3: Drug treatment for disorders affecting the central nervous system. Introduction to the CNS and drugs affecting the brain -- Neurodegenerative disorders -- Drug therapy for Alzheimer's disease and other cognitive disorders/dementias -- Pharmacotherapy of basal ganglia disorders: Parkinson's disease and Huntington's disease -- Drug therapy for psychoses and bipolar disorder -- Drug therapy for depression and anxiety -- Drug therapy for the management of attention deficit hyperactivity disorder -- Drug therapy for insomnia and the hypersomnias -- Drug therapy for managing obesity and eating disorders -- Treatment of seizure disorders -- Drug therapy to control spasticity disorders -- Ethanol, other alcohols, and drugs for alcohol use disorder -- Illicit psychoactive compounds and substance use disorder -- Section 4: Drug therapy for pain management. Introduction -- General anesthetics -- Local anesthetics -- Opioid analgesics -- Nonsteroidal anti-inflammatory agents and acetaminophen -- Cannabinoids -- Section 5: Treatment of inflammatory, allergic and immunologic disorders. Drug therapy for migraine headache -- Drug therapy for gout and hyperuricemia -- Drug treatment for allergic reactions -- Immunosuppressants for autoimmune disorders and organ transplantation -- Drug therapy for rheumatoid arthritis -- Section 6: Drug treatment for cardiovascular diseases. Introduction to the cardiovascular system and the regulation of blood pressure and heart rate -- Overview of hypertension management and drugs that decrease sympathetic tone -- Diuretics and drugs that affect volume and electrolyte content -- Drugs affecting the renin-angiotensin-aldosterone system -- Calcium channel blockers -- Vasodilators -- Drug therapy for hyperlipidemias and atherosclerotic cardiovascular disease -- Drug therapy for myocardial ischemia and angina pectoris -- Treatment of heart failure: cardiac glycosides, phosphodiesterase inhibitors and other agents -- Antiarrhythmic drugs -- Anticoagulant, antiplatelet and thrombolytic agents -- Drug therapy for hemophilia and the anemias --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Section 7: Treatment of endocrine disorders. Introduction to endocrine pharmacology -- Treatment of hypothalamic and pituitary disorders -- Treatment of adrenalcorticosteroid disorders -- Female hormone regulation -- Androgens, antiandrogens and their clinical uses -- Drug therapy for the management of diabetes -- Drug therapy for the management of thyroid disorders -- Calcium regulating hormones and agents affecting bone -- Section 8: Chemotherapy. Infectious diseases -- Principles of antimicrobial use -- Bacterial cell wall synthesis inhibitors -- Inhibitors of protein synthesis -- Drugs that target DNA -- Antimycobacterial drugs and the treatment of tuberculosis and leprosy -- Drug therapy for resistant organisms -- Parasitic diseases -- Antifungal agents -- Antimalarial and other antiprotozoal agents -- Antihelmintics -- Viruses -- Drug therapy for non-HIV viral infections -- Drugs for HIV and related opportunistic infections -- Cancer -- Introduction and therapeutic principles -- Cytotoxic agents -- Targeted agents -- Section 9: Special considerations. Therapeutic use of hematopoietic growth factors, vitamins and minerals -- Gastrointestinal disorders and their treatment -- Pharmacological treatment of asthma and COPD -- The role of neutraceuticals and natural products -- Essentials of toxicology -- Therapeutic considerations for pregnant, pediatric, geriatric and obese individuals.
520 ## - SUMMARY, ETC.
Summary, etc. "Focusing on the essential aspects of pharmacology you need to know, Brody's Human Pharmacology, 6th Edition, keeps you fully up to date with all that's new in the field. Streamlined content, a new organizational approach, enhanced online components, and thoroughly updated information ensure your grasp of key concepts and prepare you for exams. Nearly 500 full-color illustrations explain important processes, while color-coded boxes for major drugs, therapeutic overviews, clinical problems, and trade names reinforce your mastery of the information"--Publisher's description.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on online resource; title from electronic title page (ClinicalKey, viewed August 2, 2018).
590 ## - LOCAL NOTE (RLIN)
Local note Elsevier
Provenance (VM) [OBSOLETE] Elsevier ClinicalKey eBooks
590 ## - LOCAL NOTE (RLIN)
Local note Elsevier
Provenance (VM) [OBSOLETE] Elsevier ClinicalKey
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology.
Authority record control number or standard number http://id.loc.gov/authorities/subjects/sh85100599
9 (RLIN) 2624
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chemotherapy.
Authority record control number or standard number http://id.loc.gov/authorities/subjects/sh85023041
9 (RLIN) 5828
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chemotherapy.
Source of heading or term fast
Authority record control number or standard number (OCoLC)fst00853595
9 (RLIN) 5828
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology.
Source of heading or term fast
Authority record control number or standard number (OCoLC)fst01060259
9 (RLIN) 2624
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology.
9 (RLIN) 2624
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy.
9 (RLIN) 2792
650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans.
9 (RLIN) 11900
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
9 (RLIN) 10279
655 #0 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
9 (RLIN) 10279
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wecker, Lynn,
Relator term editor.
Authority record control number or standard number http://id.loc.gov/authorities/names/n2005181854
9 (RLIN) 16397
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Taylor, David A.
Fuller form of name (David Alan),
Dates associated with a name 1948-
Relator term editor.
Authority record control number or standard number http://id.loc.gov/authorities/names/n2018180568
9 (RLIN) 16398
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Theobald, Robert James,
Titles and other words associated with a name Jr.,
Relator term editor.
Authority record control number or standard number http://id.loc.gov/authorities/names/n2018180565
9 (RLIN) 16399
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Brody's human pharmacology.
Edition Sixth edition
Place, publisher, and date of publication Philadelphia : Elsevier, [2019]
International Standard Book Number 9780323476522
Record control number (DLC) 2018003347
-- (OCoLC)1021066375
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20150057550">https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20150057550</a>
Link text Click here for the e-copy
938 ## -
-- YBP Library Services
-- YANK
-- 15711010
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Online Electronic Resource
994 ## -
-- 92
-- PHERM

No items available.